Lv11
80 积分 2024-06-24 加入
Upadacitinib for the treatment of active non-radiographic axial spondyloarthritis (SELECT-AXIS 2): a randomised, double-blind, placebo-controlled, phase 3 trial
2天前
已完结
Efficacy and safety of adalimumab in Chinese adults with active ankylosing spondylitis: results of a randomised, controlled trial
2个月前
已完结
Efficacy and safety of adalimumab in patients with ankylosing spondylitis: Results of a multicenter, randomized, double‐blind, placebo‐controlled trial
2个月前
已完结
Efficacy and safety results from the randomized controlled comparative study of adalimumab vs. methotrexate vs. placebo in patients with psoriasis (CHAMPION)
2个月前
已完结
JAK inhibitors: a novel, safe, and efficacious therapy for pyoderma gangrenosum
3个月前
已完结
Refractory pyoderma gangrenosum associated with rheumatoid arthritis successfully treated with upadacitinib. Comments on: “JAK inhibitors: a novel, safe, and efficacious therapy for pyoderma gangrenosum”
3个月前
已完结
Comorbidity clusters in patients with rheumatoid arthritis identify a patient phenotype with a favourable prognosis
4个月前
已完结
Treating chronic diseases without tackling excess adiposity promotes multimorbidity
4个月前
已完结
皖公网安备34019202002308
